Early referral to palliative care: a randomised trial of patients with metastatic cancer and a survival expectation of less than 12 months
Not Applicable
Completed
- Conditions
- Metastatic incurable cancerCancer - Any cancer
- Registration Number
- ACTRN12611001137987
- Lead Sponsor
- Martin Henry Norman Tattersall
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Metastatic and incurable cancer with a life expectation of <12 months
Exclusion Criteria
previous contact with palliative care
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie palliative care's impact on quality of life in metastatic cancer patients with <12 months survival expectation as studied in ACTRN12611001137987?
How does early palliative care intervention compare to standard-of-care in improving survival outcomes for incurable cancer patients with metastatic disease?
Are there specific biomarkers associated with enhanced quality of life outcomes in ACTRN12611001137987's early palliative care trial for metastatic cancer patients?
What adverse events are commonly reported in palliative care trials for metastatic cancer patients with limited survival expectations and how are they managed?
What combination approaches or competitor therapies show promise in improving quality of life for incurable cancer patients alongside early palliative care as explored in ACTRN12611001137987?